Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Barry Kapik
Comparison of Data Characterising the Clinical Effectiveness of the Fluocinolone Intravitreal Implant (ILUVIEN) in Patients With Diabetic Macular Edema From the Real World, Non-Interventional ICE-UK Study and the FAME Randomized Controlled Trials
Current Medical Research and Opinion
Medicine
Related publications
Three-Year Results From the Retro-Ideal Study: Real-World Data From Diabetic Macular Edema (DME) Patients Treated With ILUVIEN® (0.19 Mg Fluocinolone Acetonide Implant)
European Journal of Ophthalmology
Medicine
Ophthalmology
Clinical Effectiveness of Intravitreal Fluocinolone Acetonide (FAc) (ILUVIEN™) in Patients With Diabetic Macular Oedema (DMO) Refractory to Prior Therapy: The Manchester Experience
Ophthalmology and Therapy
Ophthalmology
Real-World Experience of Fluocinolone Acetonide (0.2 Μg/Day) Intravitreal Implant in the Treatment of Diabetic Macular Oedema
European Ophthalmic Review
Efficacy and Safety of Sustained-Delivery Fluocinolone Acetonide Intravitreal Implant in Patients With Chronic Diabetic Macular Edema Insufficiently Responsive to Available Therapies: A Real-Life Study
Clinical Ophthalmology
Ophthalmology
Intravitreal Ranibizumab Therapy for Diabetic Macular Edema in Routine Practice: Two-Year Real-Life Data From a Non-Interventional, Multicenter Study in Germany
Diabetes Therapy
Internal Medicine
Endocrinology
Metabolism
Diabetes
Dexamethasone Intravitreal Implant in Diabetic Macular Edema: Real-Life Data From a Prospective Study and Predictive Factors for Visual Outcome
Diabetes Therapy
Internal Medicine
Endocrinology
Metabolism
Diabetes
Efficacy and Safety of Corticosteroid Implant (Fluocinolone Acetonide (FAc) 0.2 Μ G/Day, Iluvien ® ) for Management of Diabetic Macular Edema (DME): A Real‐life Study
Acta Ophthalmologica
Medicine
Ophthalmology
Intravitreal Corticosteroids in the Management of Diabetic Macular Edema
Current Ophthalmology Reports
Ophthalmology
The USER Study: A Chart Review of Patients Receiving a 0.2 Μg/Day Fluocinolone Acetonide Implant for Diabetic Macular Edema
Ophthalmology and Therapy
Ophthalmology
